Skip to content
中文产业新闻评分64Chinese source

先声药业曲拉西利获NMPA批准新适应症，覆盖复发广泛期小细胞肺癌

先声药业「曲拉西利」获批新适应症，针对小细胞肺癌丨产业新闻

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.